Electroporation-mediated gene therapy

Non-viral gene transfer is markedly enhanced by the application of in vivo electroporation. Electroporation is a safe and efficient system to introduce genes to a wide variety of tissues, including skeletal muscle, tumors, kidney, liver and skin. Electroporation has been demonstrated to be effective in numerous disease models. This review focuses on the principles of electroporation and the target tissues employed for gene therapy. Based on the accumulation of positive results, the first clinical study for the treatment of malignant melanoma is now underway, and preclinical studies have suggested that electroporation is useful as a gene therapy protocol.

[1]  J. Scheerlinck,et al.  Co-delivery of plasmid-encoded cytokines modulates the immune response to a DNA vaccine delivered by in vivo electroporation. , 2007, Vaccine.

[2]  T. Geiser,et al.  Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[3]  C. Cepko,et al.  Controlled expression of transgenes introduced by in vivo electroporation , 2007, Proceedings of the National Academy of Sciences.

[4]  N. Fujii,et al.  Targeting of interstitial cells using a simple gene-transfer strategy. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  H. Kawachi,et al.  Transcription factor Ets-1 is essential for mesangial matrix remodeling. , 2006, Kidney international.

[6]  D. Coppola,et al.  Evaluation of Toxicity following Electrically Mediated Interleukin-12 Gene Delivery in a B16 Mouse Melanoma Model , 2006, Clinical Cancer Research.

[7]  Bin Sun,et al.  Mechanism of in vivo DNA transport into cells by electroporation: electrophoresis across the plasma membrane may not be involved , 2006, The journal of gene medicine.

[8]  Yuhong Xu,et al.  Inhibition of hepatitis B virus replication by various RNAi constructs and their pharmacodynamic properties. , 2005, The Journal of general virology.

[9]  A. Nicosia,et al.  In vivo DNA gene electro‐transfer: a systematic analysis of different electrical parameters , 2005, The journal of gene medicine.

[10]  Shulin Li,et al.  Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  L. Mir,et al.  Electrophoretic component of electric pulses determines the efficacy of in vivo DNA electrotransfer. , 2005, Human gene therapy.

[12]  M. Lenter,et al.  In Vivo Human MCP-1 Transfection in Porcine Arteries by Intravascular Electroporation , 2005, Pharmaceutical Research.

[13]  J. Miyazaki,et al.  Cancer gene therapy using in vivo electroporation of Flt3-ligand. , 2005, International journal of oncology.

[14]  Jianjun Chen,et al.  Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation. , 2005, Vaccine.

[15]  H. Kawachi,et al.  Exploring RNA interference as a therapeutic strategy for renal disease , 2005, Gene Therapy.

[16]  M. Hori,et al.  Electroporation-mediated HGF gene transfection protected the kidney against graft injury , 2005, Gene Therapy.

[17]  Jagdish Singh,et al.  Skin targeted DNA vaccine delivery using electroporation in rabbits. I: efficacy. , 2005, International journal of pharmaceutics.

[18]  M. Hashida,et al.  Hepatocyte-targeted gene transfer by combination of vascularly delivered plasmid DNA and in vivo electroporation , 2005, Gene Therapy.

[19]  Y. C. Long,et al.  FVIII gene delivery by muscle electroporation corrects murine hemophilia A , 2005, The journal of gene medicine.

[20]  R. Dummer,et al.  Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy. , 2005, Human gene therapy.

[21]  T. Tjelle,et al.  Gene expression and immune response kinetics using electroporation‐mediated DNA delivery to muscle , 2005, The journal of gene medicine.

[22]  G. Ciliberto,et al.  Gene electro‐transfer of an improved erythropoietin plasmid in mice and non‐human primates , 2005, The journal of gene medicine.

[23]  O. Mimura,et al.  Effect of GDNF gene transfer into axotomized retinal ganglion cells using in vivo electroporation with a contact lens-type electrode , 2005, Gene Therapy.

[24]  G. Prud’homme.  DNA vaccination against tumors , 2005, The journal of gene medicine.

[25]  Y. Maehara,et al.  IL-12 Gene Therapy Is an Effective Therapeutic Strategy for Hepatocellular Carcinoma in Immunosuppressed Mice1 , 2004, The Journal of Immunology.

[26]  G. Marti,et al.  Electroporative transfection with KGF-1 DNA improves wound healing in a diabetic mouse model , 2004, Gene Therapy.

[27]  T. Nishi,et al.  Electroporation-mediated muscarinic M3 receptor gene transfer into rat urinary bladder. , 2004, International journal of urology : official journal of the Japanese Urological Association.

[28]  Leaf Huang,et al.  Electroporatic delivery of TGF-beta1 gene works synergistically with electric therapy to enhance diabetic wound healing in db/db mice. , 2004, The Journal of investigative dermatology.

[29]  Jong‐Mook Kim,et al.  Electrotransfer of human IL‐1Ra into skeletal muscles reduces the incidence of murine collagen‐induced arthritis , 2004, The journal of gene medicine.

[30]  Hiroshi Kawachi,et al.  DNAzyme for TGF-beta suppressed extracellular matrix accumulation in experimental glomerulonephritis. , 2004, Kidney international.

[31]  Tanja Cufer,et al.  Electrochemotherapy with cisplatin of cutaneous tumor lesions in breast cancer , 2004, Anti-cancer drugs.

[32]  Toshikazu Nakamura,et al.  Electroporation-mediated HGF gene transfer ameliorated cyclosporine nephrotoxicity. , 2004, Kidney international.

[33]  L. Babiuk,et al.  Strategies for improved formulation and delivery of DNA vaccines to veterinary target species , 2004, Immunological reviews.

[34]  Y. Isaka,et al.  SUPPRESSION OF CYCLOSPORINE A NEPHROTOXICITY IN VIVO BY TRANSFORMING GROWTH FACTOR β RECEPTOR-IMMUNOGLOBULIN G CHIMERIC PROTEIN , 2004, Transplantation.

[35]  Kunio Matsumoto,et al.  Skeletal muscle targeting in vivo electroporation-mediated HGF gene therapy of bleomycin-induced pulmonary fibrosis in mice , 2004, Laboratory Investigation.

[36]  R. Draghia‐Akli,et al.  Long-term effects of plasmid-mediated growth hormone releasing hormone in dogs , 2004, Cancer Gene Therapy.

[37]  T. Tjelle,et al.  In vivo electroporation improves immune responses to DNA vaccination in sheep. , 2004, Vaccine.

[38]  N. Ichimaru,et al.  Direct transfer of hepatocyte growth factor gene into kidney suppresses cyclosporin A nephrotoxicity in rats. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  M. Tao,et al.  In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine. , 2004, Vaccine.

[40]  J. Miyazaki,et al.  Post‐secretion neutralization of transgene‐derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle , 2004, The journal of gene medicine.

[41]  Julie Gehl,et al.  Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. , 2003, Cancer treatment reviews.

[42]  D. Scherman,et al.  Enhanced antitumor activity of a combination of MBD2‐antisense electrotransfer gene therapy and bleomycin electrochemotherapy , 2003, The journal of gene medicine.

[43]  J. Miyazaki,et al.  Effects of Erythropoietin-Gene Electrotransfer in Rats with Adenine-Induced Renal Failure , 2003, American Journal of Nephrology.

[44]  H. Lee,et al.  Electro-gene therapy of collagen-induced arthritis by using an expression plasmid for the soluble p75 tumor necrosis factor receptor-Fc fusion protein , 2003, Gene Therapy.

[45]  R. Seder,et al.  DNA vaccination: the answer to stable, protective T-cell memory? , 2003, Current opinion in immunology.

[46]  M. Monden,et al.  Electroporation‐mediated ex vivo gene transfer into graft not requiring injection pressure in orthotopic liver transplantation , 2003, The journal of gene medicine.

[47]  M. Monden,et al.  Gene transfer into the liver by plasmid injection into the portal vein combined with electroporation , 2003, Journal of Gene Medicine.

[48]  T. Yamano,et al.  A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma , 2003, Cancer Gene Therapy.

[49]  G Hewinson,et al.  DNA Injection in Combination with Electroporation: a Novel Method for Vaccination of Farmed Ruminants , 2003, Scandinavian journal of immunology.

[50]  L. Babiuk,et al.  Induction of immune responses by DNA vaccines in large animals. , 2003, Vaccine.

[51]  Y. Terada,et al.  Ligand-regulatable erythropoietin production by plasmid injection and in vivo electroporation. , 2002, Kidney International.

[52]  C. Slaughter,et al.  Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. , 2002, Blood.

[53]  G. Prud’homme,et al.  In vivo generation of dendritic cells by intramuscular codelivery of FLT3 ligand and GM-CSF plasmids. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[54]  S. Szala,et al.  Electrotransfer of gene encoding endostatin into normal and neoplastic mouse tissues: Inhibition of primary tumor growth and metastatic spread , 2002, Cancer Gene Therapy.

[55]  Lei Zhang,et al.  Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation. , 2002, Biochimica et biophysica acta.

[56]  T. Oshitari,et al.  Rescue of axotomized retinal ganglion cells by BDNF gene electroporation in adult rats. , 2002, Investigative ophthalmology & visual science.

[57]  D. Coppola,et al.  IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[58]  G. Trinchieri,et al.  Interleukin-12 in anti-tumor immunity and immunotherapy. , 2002, Cytokine & growth factor reviews.

[59]  K. Dono,et al.  Attenuated acute liver injury in mice by naked hepatocyte growth factor gene transfer into skeletal muscle with electroporation , 2002, Gut.

[60]  M. Hori,et al.  Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial α-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats , 2002, Gene Therapy.

[61]  L. Mir,et al.  Mechanisms of in vivo DNA electrotransfer: respective contributions of cell electropermeabilization and DNA electrophoresis. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[62]  J. Miyazaki,et al.  Electroporation-mediated tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L gene therapy for hepatocellular carcinoma. , 2002, Human gene therapy.

[63]  G. Blancho,et al.  Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[64]  Feng Liu,et al.  Improving plasmid DNA‐mediated liver gene transfer by prolonging its retention in the hepatic vasculature , 2001, The journal of gene medicine.

[65]  F. Marumo,et al.  Efficient and ligand-dependent regulated erythropoietin production by naked dna injection and in vivo electroporation. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[66]  D. Curiel,et al.  A novel system for mitigation of ectopic transgene expression induced by adenoviral vectors , 2001, Gene Therapy.

[67]  H. Hirai,et al.  In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice , 2001, Gene Therapy.

[68]  M. Hori,et al.  Electroporation-mediated PDGF receptor-IgG chimera gene transfer ameliorates experimental glomerulonephritis. , 2001, Kidney international.

[69]  M. Hori,et al.  Electroporation-mediated gene transfer that targets glomeruli. , 2001, Journal of the American Society of Nephrology : JASN.

[70]  A. Theofilopoulos,et al.  Anticytokine gene therapy of autoimmune diseases , 2001, Expert opinion on biological therapy.

[71]  D. Scherman,et al.  Improvement of mouse β-thalassemia by electrotransfer of erythropoietin cDNA , 2001 .

[72]  P. Delaère,et al.  Partial prevention of cisplatin-induced neuropathy by electroporation-mediated nonviral gene transfer. , 2001, Human gene therapy.

[73]  J. Miyazaki,et al.  Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats , 2001, Gene Therapy.

[74]  A. Theofilopoulos,et al.  Immunotherapeutic gene transfer into muscle. , 2001, Trends in immunology.

[75]  R. Malone,et al.  Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[76]  M. Jaroszeski,et al.  Treatment of hepatocellular carcinoma in a rat model using electrochemotherapy. , 2001, European journal of cancer.

[77]  C. Smythe,et al.  Treatment of murine lupus with cDNA encoding IFN-?R/Fc , 2000 .

[78]  D. Scherman,et al.  High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[79]  R. Malone,et al.  Efficient nonviral cutaneous transfection. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[80]  D. Moradpour,et al.  Ligand-mediated retargeting of recombinant adenovirus for gene transfer in vivo , 2000, Gene Therapy.

[81]  Y. Kaneda,et al.  Gene transfer targeting interstitial fibroblasts by the artificial viral envelope-type hemagglutinating virus of Japan liposome method. , 2000, Kidney international.

[82]  J. Ulmer,et al.  Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo , 2000, The Journal of Immunology.

[83]  M. Bureau,et al.  Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. , 2000, Biochimica et biophysica acta.

[84]  D. Kono,et al.  Treatment of murine lupus with cDNA encoding IFN-γR/Fc , 2000 .

[85]  Dexi Liu,et al.  Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA , 1999, Gene Therapy.

[86]  J. Wolff,et al.  High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. , 1999, Human gene therapy.

[87]  R. Cortese,et al.  Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[88]  M. Bureau,et al.  High-efficiency gene transfer into skeletal muscle mediated by electric pulses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[89]  N. Yang,et al.  Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity: a direct comparison with systemic IL-12 protein therapy. , 1999, Journal of immunotherapy.

[90]  A. Pilaro,et al.  Preclinical Development Strategies for Novel Gene Therapeutic Products , 1999, Toxicologic pathology.

[91]  Y. Sung,et al.  Comparison of various expression plasmids for the induction of immune response by DNA immunization. , 1997, Molecules and cells.

[92]  Darius Moradpour,et al.  In vivo gene electroinjection and expression in rat liver , 1996, FEBS letters.

[93]  J. Kuratsu,et al.  High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. , 1996, Cancer research.

[94]  S. Rosenberg,et al.  T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years , 1995, Science.

[95]  L. Mir,et al.  Electrochemotherapy, a new antitumor treatment. First clinical phase I‐II trial , 1993, Cancer.

[96]  J. Ulmer,et al.  Heterologous protection against influenza by injection of DNA encoding a viral protein. , 1993, Science.

[97]  D. Tang,et al.  Genetic immunization is a simple method for eliciting an immune response , 1992, Nature.

[98]  T. Tsong,et al.  Electroporation of cell membranes. , 1991, Biophysical journal.

[99]  T. Palmer,et al.  Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[100]  T. Reese,et al.  Changes in membrane structure induced by electroporation as revealed by rapid-freezing electron microscopy. , 1990, Biophysical journal.

[101]  T. Tsong,et al.  Study of mechanisms of electric field-induced DNA transfection. I. DNA entry by surface binding and diffusion through membrane pores. , 1990, Biophysical journal.

[102]  L. Chernomordik,et al.  Electrostimulated uptake of DNA by liposomes. , 1990, Biochimica et biophysica acta.

[103]  H. Potter,et al.  Electroporation in biology: methods, applications, and instrumentation. , 1988, Analytical biochemistry.

[104]  D. Yee,et al.  Electroporation: parameters affecting transfer of DNA into mammalian cells. , 1987, Analytical biochemistry.

[105]  N. Drinkwater,et al.  Chemically induced mutagenesis in a shuttle vector with a low-background mutant frequency. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[106]  U. Zimmermann,et al.  Electric field-mediated fusion and related electrical phenomena. , 1982, Biochimica et biophysica acta.

[107]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[108]  R. Benz,et al.  The resealing process of lipid bilayers after reversible electrical breakdown. , 1981, Biochimica et biophysica acta.

[109]  R. Benz,et al.  Pulse-length dependence of the electrical breakdown in lipid bilayer membranes. , 1980, Biochimica et biophysica acta.

[110]  U. Zimmermann,et al.  Transcellular ion flow in Escherichia coli B and electrical sizing of bacterias. , 1973, Biophysical journal.

[111]  H. Coster,et al.  A quantitative analysis of the voltage-current relationships of fixed charge membranes and the associated property of "punch-through". , 1965, Biophysical journal.

[112]  X. Zhang,et al.  Regression of tumors by IFN-α electroporation gene therapy and analysis of the responsible genes by cDNA array , 2002, Gene Therapy.

[113]  M. Shibata,et al.  Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation , 2002, Cancer Gene Therapy.

[114]  T. Oshitari,et al.  Gene transfer into retinal ganglion cells by in vivo electroporation: a new approach. , 2002, Micron.

[115]  R. Heller,et al.  Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[116]  S. Masuda,et al.  In vivo gene electroporation in skeletal muscle with special reference to the duration of gene expression. , 2001, International journal of molecular medicine.

[117]  T. Muramatsu,et al.  In vivo gene electroporation confers nutritionally-regulated foreign gene expression in the liver. , 2001, International journal of molecular medicine.

[118]  H. Aihara,et al.  Gene transfer into muscle by electroporation in vivo. , 1998, Nature biotechnology.

[119]  S. Orlowski,et al.  First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. , 1997, British Journal of Cancer.